Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Dr. Sophia Balzora is a consultant for Bristol Myers Squibb, Janssen, Pfizer and Takeda.
Dr. Alan Moss and Ms. Latonia Ward have no relevant financial relationships to disclose.
The speakers do not plan on discussing unlabeled/investigational uses of a commercial product.
Planning Team Disclosures
The following members of Boston University Chobanian & Avedisian School of Medicine, Center for Continuing Education have no relevant financial relationships to disclose:
Michael Burk, BS, Senior Program Manager, BU CCE
Chris Drury, MA, MA medical writer of Quill Consulting
Susan Dybowski, RN, Nursing Advisor of Boston Children’s Hospital
Sharmeel Wasan, MD, CME Physician Advisory, of Boston University School of Medicine and Boston Medical Center.